Verified Supplement Data Primary-sourced

Lactoferrin: Iron, Immune & Gut Research (2 Retracted Trials)

By Erin Rose · Updated · Methodology

Educational overview — not medical advice. Lactoferrin is a milk-derived glycoprotein with no established RDA or upper limit; anyone with a diagnosed cow's-milk-protein allergy should not assume it's safe by default. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Two of the largest, most-cited "lactoferrin beats iron for pregnancy anemia" trials were formally retracted in December 2023. Rezk et al. 2016 (PMID 26037728) and Darwish et al. 2019 (PMID 29338568) are exactly the kind of large, specific studies an AI model or a lazy blog post surfaces as "proof" — and most competitor content still doesn't know they were withdrawn. That leaves three real, thinner-than-advertised threads: iron/anemia (a genuine mechanistic story, but a smaller surviving trial base), immune/infection (modest, mostly infant-formula trials, and two honest COVID-era nulls), and gut (H. pylori is adjunct-only; neonatal NEC/sepsis is a NICU context, not a general-population claim). This page routes to the honest version of all three.

As an Amazon Associate we earn from qualifying purchases. On best lactoferrin, products are compared by cost per mg and cost per day, and by whether the apolactoferrin (iron-depleted) form is disclosed — not by commissions.

Start here

What lactoferrin is, and the species question that gets skipped

Lactoferrin is an iron-binding glycoprotein found in milk, tears, saliva, and other secretions, where it plays a role in iron transport and innate immune defense. Almost every product sold and most trials conducted use bovine lactoferrin (from cow's milk) — but the human evidence base is a genuinely messy mix of bovine, recombinant-human, and endogenous-human-lactoferrin research, and most marketing copy doesn't distinguish them. That distinction matters concretely: the mechanistic iron-absorption trial most often cited to explain why lactoferrin might rival iron salts (Lönnerdal & Bryant 2006) tested recombinant human lactoferrin, a rice-expressed research compound — not the bovine product on the shelf. This page and its four spokes name the source species every time a study is cited, because letting a human-lactoferrin mechanism paper lend credibility to a bovine retail capsule is exactly the kind of blur this site exists to avoid.

The retraction story, in full

Before anything else: Rezk et al. 2016 and Darwish et al. 2019, both published in the Journal of Maternal-Fetal & Neonatal Medicine, were large, specific pregnancy-anemia trials that appeared to show lactoferrin matching or beating iron therapy. Both were formally retracted in December 2023 — retraction notices at PMID 37466255 and PMID 36658737. The Darwish trial also drew a pre-retraction statistical-concerns letter (PMID 29690808) with a published author reply (PMID 29877119) back in 2019. Neither retraction notice's fetched text states the specific reason, so this site treats both as data-integrity retractions rather than benign administrative ones, and neither trial's findings are cited as evidence anywhere on this site. Why this matters beyond the two trials themselves: a 2017 meta-analysis in this evidence base (PMID 29059584) was published a year after Rezk 2016 in the same narrow niche and very likely pooled the now-retracted trial, and even the most recent 2024 systematic review (PMID 38291525) doesn't visibly address the retractions in its abstract. The honest, still-standing evidence for lactoferrin vs. iron in pregnancy is thinner than the retracted-trial-inflated literature makes it look — the full breakdown, including what does survive, is on the iron-deficiency-anemia page.

Three threads, read honestly

Iron/anemia is the most interesting real signal: lactoferrin binds iron directly, which plausibly modulates absorption differently than ferrous salts, and the one surviving primary trial (Nappi et al. 2009, n=97, not retracted) found bovine lactoferrin matched ferrous sulfate on hemoglobin and ferritin restoration with significantly fewer GI side effects. That's a real, modest finding — not the sweeping "lactoferrin beats iron" claim the retracted trials implied. Immune/infection evidence is modest and mixed: a 2021 meta-analysis (Ali et al. 2021) found a real pooled respiratory-infection risk reduction, but it's dominated by infant-formula-fortification trials rather than adult supplement users, and the two dedicated COVID-19 RCTs — Navarro et al. 2023 and Matino et al. 2023 — both missed their primary endpoints. Any claim that lactoferrin prevents or treats COVID-19 is directly contradicted by this site's own best evidence. Gut evidence splits into two clinical contexts, not general-population claims: H. pylori eradication is real but adjunct-only, added to standard antibiotic therapy (Hablass et al. 2021); and neonatal NEC/sepsis is a NICU/preterm-infant setting where the most current synthesis (Wang et al. 2023, JAMA Pediatrics; a co-author discloses Lallemand and Nestlé industry ties) found lactoferrin alone showed no significant mortality or NEC benefit — only combined with probiotics did sepsis risk drop. Neither gut thread has anything to do with a healthy adult buying a capsule off Amazon.

The one-line takeaway Lactoferrin's best-known "wins" lean heavily on data that no longer holds up: two of its biggest pregnancy-anemia trials are retracted, and both dedicated COVID-19 trials are clean nulls. What survives is a modest, real iron-absorption story (Nappi 2009), a modest respiratory-infection signal mostly from infant-formula trials, and gut evidence that's adjunct-only or NICU-specific. See best lactoferrin for cost-per-day picks, or start with the iron page for the fullest version of the retraction story.

Bovine lactoferrin vs. bovine colostrum: don't conflate them

Lactoferrin is one of colostrum's marketed active glycoproteins, and colostrum products often cite their lactoferrin content as a selling point — but colostrum contains lactoferrin as one of many components at a much lower concentration per serving than a dedicated lactoferrin supplement. If you're buying colostrum specifically for its lactoferrin, you're likely getting a fraction of what a 250-300mg lactoferrin capsule delivers; see the colostrum hub for that category's own separate evidence (its strongest thread is gut-lining protection and exercise-related gut permeability, not lactoferrin content specifically). For iron-deficiency anemia specifically, the iron category is the direct comparison point — standard iron salts remain the first-line, most-studied treatment; lactoferrin is, at best, a reasonable second-line option for people who can't tolerate iron salts' GI effects, not a proven head-to-head replacement.

Safety, in brief

Bovine lactoferrin has a good short-term safety record across the trials in this evidence base — Matino 2023 explicitly concluded it was "safe and tolerable" even at 800mg/day, and Sachdeva 2009's H. pylori meta-analysis found no significant difference in adverse events vs. control. Mild GI effects are possible. Because lactoferrin is a milk-derived protein, anyone with a diagnosed cow's-milk-protein allergy should not assume it's safe by default — that caution should be explicit, not just implied by "milk-derived" language. There is no established RDA, AI, or upper limit for lactoferrin: it is not an essential nutrient with a government reference intake, it's a milk-derived glycoprotein. No positive finding in this evidence base amounts to a proven treatment, prevention, or cure claim for any disease.

Frequently asked questions

Is it true that major lactoferrin studies were retracted?

Yes. Rezk 2016 (PMID 26037728) and Darwish 2019 (PMID 29338568) were retracted in Dec 2023. Neither is cited as evidence here. The surviving pregnancy-anemia evidence leans on Nappi 2009 (PMID 19639462), which is thinner and less dramatic.

Does lactoferrin prevent or treat COVID-19?

No. Both dedicated COVID-19 RCTs (Navarro 2023, Matino 2023) missed their primary endpoints — clean nulls, not open questions.

Does lactoferrin boost the immune system?

Modestly and unevenly — a real respiratory-infection signal dominated by infant-formula trials, plus a 2026 lab-marker trial in older adults. Not a "fewer colds" clinical outcome.

Does lactoferrin cure H. pylori or help premature babies?

Neither alone. H. pylori evidence is adjunct-only (added to antibiotics). NEC/sepsis is a NICU context where lactoferrin alone showed no benefit — only combined with probiotics.

Related guides

  • Colostrum — lactoferrin is one of colostrum's active glycoproteins, at a much lower concentration per serving
  • Iron — the direct comparison category for anemia treatment
  • Probiotics — gut-health adjacency; the strongest NEC/sepsis signal is lactoferrin+probiotic combinations, not lactoferrin alone
  • Zinc — the site's other immune-support category with its own for-colds evidence page

Sources

  1. Nappi RE, et al. "Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study." Acta Obstetricia et Gynecologica Scandinavica. 2009. PMID: 19639462
  2. Lönnerdal B, Bryant A. "Absorption of iron from recombinant human lactoferrin in young US women." The American Journal of Clinical Nutrition. 2006. PMID: 16469988
  3. Abu Hashim H, et al. "Lactoferrin or ferrous salts for iron deficiency anemia in pregnancy: A meta-analysis of randomized trials." European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2017. PMID: 29059584 (⚠️ likely overlaps with the retracted Rezk 2016 trial; treat with caution).
  4. Christofi MD, et al. "The effectiveness of oral bovine lactoferrin compared to iron supplementation in patients with a low hemoglobin profile: A systematic review and meta-analysis of randomized clinical trials." BMC Nutrition. 2024. PMID: 38291525 (⚠️ I²=95.8% heterogeneity; not a clean number).
  5. ⛔ Rezk M, et al. "Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: a randomized clinical trial." 2016. PMID: 26037728 — RETRACTED Dec 2023, retraction notice "RETRACTED ARTICLE: Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: a randomized clinical trial," PMID: 37466255. Not cited as evidence.
  6. ⛔ Darwish AM, et al. "Lactoferrin plus health education versus total dose infusion (TDI) of low-molecular weight (LMW) iron dextran for treating iron deficiency anemia (IDA) in pregnancy: a randomized controlled trial." 2019. PMID: 29338568 — RETRACTED Dec 2023, retraction notice "Statement of Retraction: lactoferrin plus health education versus total dose infusion (TDI) of low-molecular weight (LMW) iron dextran for treating iron deficiency anemia (IDA) in pregnancy: a randomized controlled trial." PMID: 36658737. Not cited as evidence.
  7. Ali AS, et al. "Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials." Clinical Nutrition ESPEN. 2021. PMID: 34620326
  8. Navarro G, et al. "Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID)." Biometals. 2023. PMID: 36474100
  9. Matino E, et al. "Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial." Nutrients. 2023. PMID: 36904283
  10. Hablass FH, Lashen SA, Alsayed EA. "Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial." The Turkish Journal of Gastroenterology. 2021. PMID: 34609303
  11. Wang Y, et al. "Probiotics, Prebiotics, Lactoferrin, and Combination Products for Prevention of Mortality and Morbidity in Preterm Infants: A Systematic Review and Network Meta-Analysis." JAMA Pediatrics. 2023. PMID: 37782505 (a co-author discloses Lallemand/Nestlé industry ties).
  12. Full product dataset: /lactoferrin/cost-by-brand.json (CC BY 4.0).